Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.

Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.

Item
http://www.wikidata.org/entity/Q38257363
Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemiaPrognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.Targeting PI3K/AKT/mTOR network for treatment of leukemia.Comparison between qualitative and real-time polymerase chain reaction to evaluate minimal residual disease in children with acute lymphoblastic leukemiaChimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
P2860

Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.

Item
http://www.wikidata.org/entity/Q38257363
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Minimal residual disease in ac ...... itfalls and recent approaches.
@en
type
label
Minimal residual disease in ac ...... itfalls and recent approaches.
@en
prefLabel
Minimal residual disease in ac ...... itfalls and recent approaches.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Minimal residual disease in ac ...... itfalls and recent approaches.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698